Clinical Trial Update: Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating atezolizumab in combination with entinostat and bevacizumab in advanced renal cell carcinoma; the study was terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• Entinostat (entinostat)

Snippet

Sponsor: Roberto Pili | Conditions: Metastatic Cancer, Renal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-03-20